Humacyte, Inc. — Director's Dealing 2020

Sep 18, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Alpha Healthcare Acquisition Corp. (AHACU)
CIK: 0001818382
Period of Report: 2020-09-17

Reporting Person: Xie Yili Kevin (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class B Common Stock	$		Class A Common Stock (25000)		Direct

Footnotes

F1: As described in the registrant's registration statement on Form S-1 (File No. 333-240374) under the heading "Description of Securities--Founder Shares and Placement Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date.